Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP XpressVANCOUVER, British Columbia, June 24, 2026 (GLOBE NEWSWIRE) -- Response Biomedical Corp. (“Response”), a Canadian leader in rapid response diagnostic solutions, today announced the launch of the RAMP Xpress™, a next-generation diagnostic platform designed to deliver fast, quantitative results for key metabolic and inflammatory biomarkers. The launch reflects Response’s strategy to expand its global diagnostics portfolio through strategic technology collaborations, addressing growing global demand for accessible, high-quality testing solutions.
